Written Question·Department of Health and Social Care·UIN 3692

Alzheimer's Disease: Drugs

Tabled: 2 September 2024

Answered: 9 September 2024

Named Day

Question

Yasmin Qureshi

To ask the Secretary of State for Health and Social Care, with reference to the decision by the Medicines and Healthcare products Regulatory Agency on 22 August 2024 to licence lecanemab for patients with early stage Alzheimer's disease, what discussions

Answer

Karin Smyth

Department officials have had a number of conversations with colleagues in NHS England about their plans to support the adoption of any licensed and National Institute for Health and Care Excellence (NICE) recommended treatment for Alzheimer’s disease.The...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 3692) →